You just read:

ZyVersa Therapeutics Unveils a White Paper Fostering Education About Inflammasomes and Their Potential as a Promising Therapeutic and Diagnostic Target for Inflammatory Diseases

News provided by

ZyVersa Therapeutics, Inc.

Sep 19, 2019, 07:03 ET